Monday, May 18, 2015

Clarus Ventures Names New Partner

South San Francisco- and Cambridge, Mass.-based venture investor Clarus Ventures said this morning that it has named Michele Park, Ph.D. as a Partner at the firm. Park, based in South San Francisco, has been at Clarus since 2006. She sits on the boards of SFJ Pharmaceuticals IV, and also was on the boards of Sientra and Alilion Pharmaceuticals; she previously served at Credit Suisse First Boston. Clarus manages around $1.7 billion in the life sciences sector.